Phanes starts dosing patients in mavrostobart chem...
Category : Clinical Trial Update 29 May 2025Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company, has announced that the first p...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company, has announced that the first p...
Rocket Pharmaceuticals, Inc., a fully integrated, late-stage biotechnology company advancing an inte...
Rein Therapeutics (Rein), a biopharmaceutical company advancing a novel pipeline of first-in-class m...
Eli Lilly and Company and SiteOne Therapeutics, Inc., a private biotechnology firm developing small...
Toronto, May 2025 – GSK has officially submitted a New Drug Submission (NDS) to Health Canada...